Removal of Alpha-Methyldopa (Aldomet) in Man by Dialysis

Publisher Website
Google Scholar
Abstract
Dialytic removal of alpha-methyldopa (Aldomet) has been investigated in chronic uremic patients undergoing either hemodialysis or peritoneal dialysis, using 14C tracer techniques. A mean of 60% of the estimated absorbed radioactivity was recovered in the dialysate of 3 patients undergoing 4 hemodialyses; the mean relative dialysance of radioactivity from alpha-methyldopa and its products was 0.34. A similar amount of radioactivity was recovered in the dialysate of 2 patients undergoing peritoneal dialysis.

This publication has 0 references indexed in Scilit: